Trends in the Treatment of Multiple Myeloma

Over the past two decades, new medications approved by the U.S. Food and Drug Administration (FDA) have transformed the way multiple myeloma is treated. This progress is unmatched in any other type of cancer. Researchers expect the picture for people with multiple myeloma to improve even more as new drugs and drug combinations are studied in clinical trials. This session will discuss recent advances in pharmacologic treatment and the roll of stem cell transplantation for multiple myeloma.

Learning Objectives
At the end of this educational activity, participants should be able to

  1. Discuss recent advances in pharmacologic treatment for multiple myeloma
  2. Identify the roll of stem cell transplantation for multiple myeloma

Faculty Listing
Sagar Lonial, MD
Professor, Hematology and Medical Oncology
Vice Chair, Department of Clinical Affairs
Emory University School of Medicine
Atlanta, Georgia

Disclosures of Relevant Financial Relationships
In accordance with the ACCME Standards for Commercial SupportSM, OptumHealth Education requires all those involved in the development of activity content to disclose their relevant financial relationships. An individual has a relevant financial relationship if such person (or their spouse/partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the activity content over which the individual has control.
OptumHealth Education ensures that the content is independent of commercial bias.

Financial Relationship Key
A-Advisory Board
C-Consultant
E-Employee
G- Grant/Research Support
I-Stocks and Other Ownership Interests
S-Speakers’ Bureau
O-Other Financial or Material Support
N-Nothing to disclose
X-Will disclose onsite
Resolution Key
R1-Restricted to Best Available Evidence
R2-Removed/Altered Financial Relationship
R3-Refrain from Recommending Products or Services
R4-Peer Review of Presentation
R5-Ensure that content is independent of commercial bias
R6-Recommend an alternative speaker for this topic for the planning committee’s consideration
N/A-Not Applicable

 

Last Name

First Name

Disclosure

Resolution

Role

Abecassis

Michael

N

N/A

Planner

Chart-Hart

Sarah

UnitedHealth Group (E) (I)

R5

Planner

Gleason

Rebecca

UnitedHealth Group (E) (I)

R5

Planner

LeMaistre

C. Fred

N

N/A

Planner

Mulligan

David C.

N

N/A

Planner

Roberts

John P.

Gilead (C)

R5

Planner

Rome

Arlene

UnitedHealth Group (E) (I)

R5

Planner

Sendaydiego

Anne M.

N

N/A

Planner

Felitti

Vincent J.

N

N/A

Faculty

Method of Participation
There are no fees for participating in or receiving credit for this activity.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

Participants will receive a certificate upon successful completion of the activity, which includes the following:

  • Completing the entire activity
  • Completing the Pre- and Post-Activity Assessments, Activity Evaluation, and Application for Certificate of Credit forms

You must be logged into your account to participate in this activity. Get started by clicking “Begin” and viewing the “CE Info”; then follow the prompts at the bottom of the screen. At the end of the activity, you will be able to view, save, or print your certificate of participation. The Area of Practice you indicated in your profile corresponds with your certificate type. A complete listing of all of your activities can be found under “My Account”, “My Activities.”

Method for Calculating CE Credit
CE credit was calculated by the complexity of content.

Provided By
This activity is provided by OptumHealth Education.

Commercial Support
This activity is supported by an educational grant from Onyx Pharmaceuticals.

Hardware/Software Requirements
To view this activity you will need Internet Explorer 7.0+ or Firefox 3.0+ with Windows Media Player 9+, RealPlayer 12+, or Adobe Flash Player 9+. Be sure to disable your pop-up blocking software prior to the beginning of this activity.

Target Audience

This activity is designed to meet the educational needs of physicians, nurses, pharmacists, case managers, and other health care professionals.

Activity summary
Available credit: 
  • 1.00 ACPE - Pharmacist
  • 1.00 AMA
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 CCMC - General
Activity opens: 
11/03/2014
Activity expires: 
11/03/2016
Rating: 
0

Available Credit

  • 1.00 ACPE - Pharmacist
  • 1.00 AMA
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 CCMC - General
Please login to register.